ConforMIS News

Disclaimer: This part of our website contains archival information which should not be considered current and may no longer be accurate.

Author Archive

  • Wednesday, 8/9/17

    ConforMIS Acquires Machining and Polishing Assets from Broad Peak Manufacturing

    Acquisition expands in-house manufacturing of customized knee implants  BILLERICA, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced that it has acquired the machining and polishing assets of Broad Peak Manufacturing, LLC, a high-precision surface preparation and finishing facility.  The purchase…

    Read more »
  • Tuesday, 7/11/17

    ConforMIS Names Dan Krupp Senior Vice President U.S. Sales

    Krupp

    BILLERICA, Mass., July 11, 2017 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced that Dan Krupp has joined the Company as its Senior Vice President of U.S. Sales, effective July 3, 2017. A photo accompanying this announcement is available…

    Read more »
  • Tuesday, 6/20/17

    ConforMIS Announces FDA 510(k) Clearance for iTotal Hip System

    Segmentation of scout CT-hip3

    New hip replacement implant system builds on ConforMIS’s customized knee replacement technology and positions Company to expand in global orthopedics market Billerica, Mass. – June 20, 2017 (GLOBE NEWSWIRE) – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers knee replacement implants customized to fit each patient’s unique anatomy, today announced it has received FDA 510(k) clearance…

    Read more »
  • Tuesday, 6/13/17

    ConforMIS Announces the Publication of Clinical and Economic Study Comparing Customized Total Knee Replacement Implants to Off-the-Shelf Total Knee Replacement Implants

    Study Finds High Satisfaction Amongst Patients with iTotal CR

    Data published in Arthroplasty Today demonstrate that patients treated with customized knee implants had significantly lower adverse event rates and transfusion rates, were significantly less likely to be discharged to a rehabilitation or other high-cost post-acute care facilities, had a lower average total cost of the episode of care and had a significantly lower average…

    Read more »
  • Wednesday, 4/12/17

    ConforMIS Announces Positive Results from Customized iTotal PS Total Knee Replacement Comparative Study

    iTotal_PS_posterior-view_502x301-300x180

    First study of iTotal PS customized implants demonstrated more normal kinematics compared with leading off-the-shelf implants Bedford, Mass. – April 12, 2017 (GLOBE NEWSWIRE) – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced results from the first study of its iTotal® PS total knee replacement…

    Read more »
  • Monday, 8/3/15

    ConforMIS Announces Results of Multiple Studies of its Customized Knee Replacements Presented at the 2015 Pan Pacific International Congress for Joint Reconstruction

    ConforMIS customized knee replacement

    ConforMIS’s customized iTotal CR knee replacements demonstrate superior functional outcomes compared to off-the-shelf knee replacements in multiple studies Bedford, Mass. – August 3, 2015 – ConforMIS, Inc. (NASDAQ: CFMS) announced today results from six clinical studies presented at the 2015 Pan Pacific International Congress for Joint Reconstruction (ICJR). In an ongoing, blinded, US multicenter study, the investigators reported…

    Read more »
  • Tuesday, 7/7/15

    ConforMIS Closes Initial Public Offering

    ConforMIS customized knee replacement

    Bedford, Mass. – July 7, 2015 – ConforMIS, Inc. (NASDAQ: CFMS) announced today the closing of its initial public offering of 10,350,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts, including 1,350,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase…

    Read more »
  • Wednesday, 7/1/15

    ConforMIS CEO: Getting A Knee Up (Mad Money, CNBC)

    Philipp Lang ConforMIS CEO on CNBC Mad Money

    Click here to read the full show recap on TheStreet.com ConforMIS is not responsible for the contents or reliability of any third-party materials accessible on ConforMIS’s website, including embedded videos, audio recordings and images, or links to external websites or other third-party materials. The information contained in such third-party materials may not be accurate or…

    Read more »
  • Wednesday, 7/1/15

    ConforMIS Announces Pricing of Its Initial Public Offering

    ConforMIS customized knee replacement

    Bedford, Mass. – June 30, 2015 – ConforMIS, Inc. announced today the pricing of its initial public offering of 9,000,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by ConforMIS. In addition, ConforMIS has granted the underwriters an option to…

    Read more »
  • Friday, 4/17/15

    ConforMIS Announces Settlement of Patent Infringement Lawsuits

    ConforMIS customized knee replacement

    Licenses Expand the Footprint of ConforMIS’ Patented Patient-Specific Instrumentation Technology Bedford, Mass. – April 17, 2015 – ConforMIS, Inc., a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture and sell customized joint replacement implants, today announced that it has entered into license agreements with each of Wright Medical Technology, Inc. (“Wright”) and…

    Read more »